Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients

OncoImmunology

Volumn 5, Issue 2, 2016, Pages

  Hennequin, Audrey ^a,b   Derangère, Valentin ^a,b,c   Boidot, Romain ^a,c   Apetoh, Lionel ^a,c   Vincent, Julie ^a   Orry, David ^a   Fraisse, Jean ^a   Causeret, Sylvain ^a   Martin, François ^b,c   Arnould, Laurent ^a   Beltjens, Françoise ^a   Ghiringhelli, François ^a,b,c   Ladoire, Sylvain ^a,b,c  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c INSERM   (France)

Author keywords

B cells; gastric cancer; histology; human tumors; prognosis; T bet

Indexed keywords

EID: 84959440329     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1054598     Document Type: Article

References (40)

1. J.Ferlay, I.Soerjomataram, R.Dikshit, S.Eser, C.Mathers, M.Rebelo, D.M.Parkin, D.Forman, F.Bray. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5):E359-86; PMID:25220842
2. A.Jemal, F.Bray, M.M.Center, J.Ferlay, E.Ward, D.Forman. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90; PMID:21296855
3. P.Lauren. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49; PMID:14320675
4. A.M.Bouvier, M.Sant, A.Verdecchia, D.Forman, R.Damhuis, J.Willem Coebergh, E.Crocetti, P.Crosignani, L.Gafa, G.Launoy, et al. What reasons lie behind long-term survival differences for gastric cancer within Europe? Eur J Cancer 2010; 46:1086-92; PMID:20163952; http://dx.doi.org/10.1016/j.ejca.2010.01.019
5. M.D.Vesely, M.H.Kershaw, R.D.Schreiber, M.J.Smyth. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29:235-71; PMID:21219185; http://dx.doi.org/10.1146/annurev-immunol-031210-101324
6. D.B.Polk, R.M.Peek, Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010; 10:403-14; PMID:20495574; http://dx.doi.org/10.1038/nrc2857
7. J.Galon, A.Costes, F.Sanchez-Cabo, A.Kirilovsky, B.Mlecnik, C.Lagorce-Pages, M.Tosolini, M.Camus, A.Berger, P.Wind, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
8. L.Zhang, J.R.Conejo-Garcia, D.Katsaros, P.A.Gimotty, M.Massobrio, G.Regnani, A.Makrigiannakis, H.Gray, K.Schlienger, M.N.Liebman, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348:203-13; PMID:12529460; http://dx.doi.org/10.1056/NEJMoa020177
9. P.Roepman, J.Jassem, E.F.Smit, T.Muley, J.Niklinski, T.van de Velde, A.T.Witteveen, W.Rzyman, A.Floore, S.Burgers, et al. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer. Clin Cancer Res 2009; 15:284-90; PMID:19118056; http://dx.doi.org/10.1158/1078-0432.CCR-08-1258
10. E.Tartour, A.Gey, X.Sastre-Garau, I.Lombard Surin, V.Mosseri, W.H.Fridman. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 1998; 90:287-94; PMID:9486814; http://dx.doi.org/10.1093/jnci/90.4.287
11. C.Marth, H.Fiegl, A.G.Zeimet, E.Muller-Holzner, M.Deibl, W.Doppler, G.Daxenbichler. Interferon-gamma expression is an independent prognostic factor in ovarian cancer. Am J Obstet Gynecol 2004; 191:1598-605; PMID:15547530; http://dx.doi.org/10.1016/j.ajog.2004.05.007
12. A.C.Mullen, F.A.High, A.S.Hutchins, H.W.Lee, A.V.Villarino, D.M.Livingston, A.L.Kung, N.Cereb, T.P.Yao, S.Y.Yang, S.L.Reiner. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001; 292:1907-10; PMID:11397944; http://dx.doi.org/10.1126/science.1059835
13. L.J.Chen, X.Zheng, Y.P.Shen, Y.B.Zhu, Q.Li, J.Chen, R.Xia, S.M.Zhou, C.P.Wu, X.G.Zhang, B.F.Lu, J.T.Jiang. Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer. Cancer Immunol Immunother 2013; 62:553-61; PMID:23090288; http://dx.doi.org/10.1007/s00262-012-1358-6
14. L.H.Glimcher. Trawling for treasure: tales of T-bet. Nat Immunol 2007; 8:448-50; PMID:17440449; http://dx.doi.org/10.1038/ni0507-448
15. M.C.Dieu-Nosjean, M.Antoine, C.Danel, D.Heudes, M.Wislez, V.Poulot, N.Rabbe, L.Laurans, E.Tartour, L.de Chaisemartin, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008; 26:4410-7; PMID:18802153; http://dx.doi.org/10.1200/JCO.2007.15.0284
16. J.Goc, C.Germain, T.K.Vo-Bourgais, A.Lupo, C.Klein, S.Knockaert, L.de Chaisemartin, H.Ouakrim, E.Becht, M.Alifano, et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res 2014; 74:705-15; PMID:24366885; http://dx.doi.org/10.1158/0008-5472.CAN-13-1342
17. J.Goc, W.H.Fridman, C.Sautes-Fridman, M.C.Dieu-Nosjean. Characteristics of tertiary lymphoid structures in primary cancers. Oncoimmunology 2013; 2:e26836; PMID:24498556; http://dx.doi.org/10.4161/onci.26836
18. S.Ishigami, S.Ueno, M.Matsumoto, H.Okumura, T.Arigami, Y.Uchikado, T.Setoyama, H.Arima, K.Sasaki, M.Kitazono, et al. Prognostic value of CD208-positive cell infiltration in gastric cancer. Cancer Immunol Immunother 2010; 59:389-95; PMID:19760221; http://dx.doi.org/10.1007/s00262-009-0758-8
19. J.D.Bouaziz, K.Yanaba, G.M.Venturi, Y.Wang, R.M.Tisch, J.C.Poe, T.F.Tedder. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A 2007; 104:20878-83; PMID:18093919; http://dx.doi.org/10.1073/pnas.0709205105
20. A.Crawford, M.Macleod, T.Schumacher, L.Corlett, D.Gray. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol 2006; 176:3498-506; PMID:16517718; http://dx.doi.org/10.4049/jimmunol.176.6.3498
21. A.Ladanyi, J.Kiss, A.Mohos, B.Somlai, G.Liszkay, K.Gilde, Z.Fejos, I.Gaudi, J.Dobos, J.Timar. Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol Immunother 2011; 60:1729-38; PMID:21779876; http://dx.doi.org/10.1007/s00262-011-1071-x
22. S.M.Mahmoud, A.H.Lee, E.C.Paish, R.D.Macmillan, I.O.Ellis, A.R.Green. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat 2012; 132:545-53; PMID:21671016; http://dx.doi.org/10.1007/s10549-011-1620-1
23. J.S.Nielsen, R.A.Sahota, K.Milne, S.E.Kost, N.J.Nesslinger, P.H.Watson, B.H.Nelson. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res 2012; 18:3281-92; PMID:22553348; http://dx.doi.org/10.1158/1078-0432.CCR-12-0234
24. C.Germain, S.Gnjatic, F.Tamzalit, S.Knockaert, R.Remark, J.Goc, A.Lepelley, E.Becht, S.Katsahian, G.Bizouard, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 2014; 189:832-44; PMID:24484236; http://dx.doi.org/10.1164/rccm.201309-1611OC
25. T.J.Curiel, G.Coukos, L.Zou, X.Alvarez, P.Cheng, P.Mottram, M.Evdemon-Hogan, J.R.Conejo-Garcia, L.Zhang, M.Burow, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-9; PMID:15322536; http://dx.doi.org/10.1038/nm1093
26. D.Wolf, A.M.Wolf, H.Rumpold, H.Fiegl, A.G.Zeimet, E.Muller-Holzner, M.Deibl, G.Gastl, E.Gunsilius, C.Marth. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 2005; 11:8326-31; PMID:16322292; http://dx.doi.org/10.1158/1078-0432.CCR-05-1244
27. L.Xu, W.Xu, S.Qiu, S.Xiong. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer. Clin Immunol 2010; 135:466-75; PMID:20181533; http://dx.doi.org/10.1016/j.clim.2010.01.014
28. S.Ladoire, F.Martin, F.Ghiringhelli. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 2011; 60:909-18; PMID:21644034; http://dx.doi.org/10.1007/s00262-011-1046-y
29. Z.Shen, S.Zhou, Y.Wang, R.L.Li, C.Zhong, C.Liang, Y.Sun. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol 2010; 136:1585-95; PMID:20221835; http://dx.doi.org/10.1007/s00432-010-0816-9
30. X.Lu, J.Liu, H.Li, W.Li, X.Wang, J.Ma, Q.Tong, K.Wu, G.Wang. Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-beta1. J Surg Oncol 2011; 104:571-7; PMID:21695703; http://dx.doi.org/10.1002/jso.22005
31. S.Ishigami, T.Arigami, Y.Uenosono, M.Matsumoto, H.Okumura, Y.Uchikado, Y.Kita, Y.Nishizono, K.Maemura, Y.Kijima, et al. Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer. Cancer Immunol Immunothera 2012; 61:1663-9; PMID:22374482; http://dx.doi.org/10.1007/s00262-012-1225-5
32. Q.Li, Q.Li, J.Chen, Y.Liu, X.Zhao, B.Tan, J.Ai, Z.Zhang, J.Song, B.Shan. Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters. Oncol Rep 2013; 30:1215-22; PMID:23807713
33. M.Haas, A.Dimmler, W.Hohenberger, G.G.Grabenbauer, G.Niedobitek, L.V.Distel. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol 2009; 9:65; PMID:19732435; http://dx.doi.org/10.1186/1471-230X-9-65
34. H.E.Lee, S.W.Chae, Y.J.Lee, M.A.Kim, H.S.Lee, B.L.Lee, W.H.Kim. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer 2008; 99:1704-11; PMID:18941457; http://dx.doi.org/10.1038/sj.bjc.6604738
35. N.A.Giraldo, E.Becht, R.Remark, D.Damotte, C.Sautes-Fridman, W.H.Fridman. The immune contexture of primary and metastatic human tumours. Curr Opin Immunol 2014; 27:8-15; PMID:24487185; http://dx.doi.org/10.1016/j.coi.2014.01.001
36. Y.Yamada, H.Saito, M.Ikeguchi. Prevalence and clinical relevance of Th17 cells in patients with gastric cancer. J Surg Res 2012; 178:685-91; PMID:22940035; http://dx.doi.org/10.1016/j.jss.2012.07.055
37. F.Martin, L.Apetoh, F.Ghiringhelli. Controversies on the role of Th17 in cancer: a TGF-beta-dependent immunosuppressive activity? Trends Mol Med 2012; 18:742-9; PMID:23083809; http://dx.doi.org/10.1016/j.molmed.2012.09.007
38. Y.Zhuang, L.S.Peng, Y.L.Zhao, Y.Shi, X.H.Mao, W.Chen, K.C.Pang, X.F.Liu, T.Liu, J.Y.Zhang, et al. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 2012; 143:951-62.e8; PMID:22710190; http://dx.doi.org/10.1053/j.gastro.2012.06.010
39. J.Lee, I.Sohn, I.G.Do, K.M.Kim, S.H.Park, J.O.Park, Y.S.Park, H.Y.Lim, T.S.Sohn, J.M.Bae, et al. Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery. PLoS One 2014; 9:e90133; PMID:24598828; http://dx.doi.org/10.1371/journal.pone.0090133
40. G.Bindea, B.Mlecnik, H.Hackl, P.Charoentong, M.Tosolini, A.Kirilovsky, W.H.Fridman, F.Pages, Z.Trajanoski, J.Galon. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009; 25:1091-3; PMID:19237447; http://dx.doi.org/10.1093/bioinformatics/btp101